S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Orion S.A. Shares Plunge on Wider-Than-Expected Fourth-Quarter Loss

Orion S.A. stock plummeted 18% on Tuesday after the carbon black supplier reported a significant fourth-quarter loss and issued a 2026 outlook that trailed Wall Street projections. Despite beating revenue estimates, the company’s widening adjusted loss triggered a sharp sell-off, extending a year-long decline for the industrial materials firm.

Orion S.A. Shares Plunge on Wider-Than-Expected Fourth-Quarter Loss

The company reported a net loss of $21.1 million, or 38 cents per share, for the final quarter of the year. This marks a sharp reversal from the $17.2 million profit recorded during the same period last year. On an adjusted basis, Orion’s loss reached 34 cents per share, far exceeding the 7-cent loss anticipated by analysts according to FactSet data.

Revenue Beats While Guidance Lags

While the bottom line suffered, Orion’s top-line performance offered a rare bright spot. Sales for the quarter reached $411.7 million, a 5.2% decline year-over-year but still comfortably ahead of the $365.7 million analysts had projected. However, this revenue resilience was overshadowed by the company's long-term financial targets which signaled potential headwinds for the sector.

Market Reaction and Future Projections

Investor confidence dampened further after Orion issued adjusted EBITDA guidance for 2026. The company expects to generate between $160 million to $200 million, a range that significantly trails the $217.9 million consensus forecast. This latest slide brings the stock's 12-month retreat to 60%, with shares trading at $5.81 as the market reassesses the supplier's recovery timeline.
Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!